Adrian Isman is a multi-lingual global business executive and Board leader with over 35 years of experience in strategic planning, M&A integration, and operations. Currently, Adrian serves as a Board Member at Bunge and Calosense Health, and holds the position of Chief Growth Officer at Calosense. Previous roles include CEO of the North America region at Louis Dreyfus Company and Chairman of the Board at Biosev SA, where Adrian played a key role in restructuring and expanding operations. Adrian's educational background includes an Advance Management Program from INSEAD and a degree in Economics from the Universidad de Buenos Aires.
This person is not in the org chart
This person is not in any teams
This person is not in any offices